• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤细胞减灭术在晚期卵巢癌中的作用:初次手术与二次手术分析

The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and second surgery.

作者信息

Wiltshaw E, Raju K S, Dawson I

出版信息

Br J Obstet Gynaecol. 1985 May;92(5):522-7. doi: 10.1111/j.1471-0528.1985.tb01359.x.

DOI:10.1111/j.1471-0528.1985.tb01359.x
PMID:3994934
Abstract

Second operations were performed as part of planned management in 53 patients 5-7 months after starting apparently successful chemotherapy. The survival of these patients is compared with 56 other patients who did not have a second laparotomy but appeared to be responding to chemotherapy equally well. Survival advantage was seen for those who had a partial remission followed by a further debulking procedure later. However, those patients who have a clinical complete remission do not seem to benefit from a second surgical intervention.

摘要

53例患者在看似成功的化疗开始5至7个月后接受了二次手术,作为计划管理的一部分。将这些患者的生存率与另外56例未进行二次剖腹手术但化疗反应同样良好的患者进行比较。那些先部分缓解随后又进行进一步减瘤手术的患者有生存优势。然而,那些临床完全缓解的患者似乎并未从二次手术干预中获益。

相似文献

1
The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and second surgery.肿瘤细胞减灭术在晚期卵巢癌中的作用:初次手术与二次手术分析
Br J Obstet Gynaecol. 1985 May;92(5):522-7. doi: 10.1111/j.1471-0528.1985.tb01359.x.
2
Advanced ovarian cancer: long-term results following chemotherapy and second-look laparotomy.
Gynecol Oncol. 1990 Dec;39(3):295-9. doi: 10.1016/0090-8258(90)90255-j.
3
[Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer].
Geburtshilfe Frauenheilkd. 1993 Dec;53(12):860-5. doi: 10.1055/s-2007-1023740.
4
Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer.
Obstet Gynecol. 1989 Jan;73(1):61-5.
5
Second-look laparotomy in ovarian cancer.卵巢癌二次剖腹探查术
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S122-7. doi: 10.1006/gyno.1994.1350.
6
Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.晚期卵巢癌经细胞减灭术和化疗后的长期生存情况。
Gynecol Oncol. 1994 Apr;53(1):27-32. doi: 10.1006/gyno.1994.1082.
7
[10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer].[晚期卵巢癌二次剖腹手术中化疗与手术的10年随访]
Med Clin (Barc). 1995 Feb 11;104(5):165-9.
8
Second look laparotomy in the management of epithelial cell carcinoma of the ovary.二次剖腹探查术在卵巢上皮细胞癌治疗中的应用
Br J Cancer. 1984 Aug;50(2):185-91. doi: 10.1038/bjc.1984.161.
9
Optimal debulking following chemotherapy of advanced-stage epithelial ovarian carcinoma.晚期上皮性卵巢癌化疗后的最佳肿瘤细胞减灭术。
J Surg Oncol. 1989 Apr;40(4):237-40. doi: 10.1002/jso.2930400407.
10
Epithelial ovarian carcinoma: principles of primary surgery.上皮性卵巢癌:初次手术原则
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S91-6. doi: 10.1006/gyno.1994.1346.

引用本文的文献

1
Surgical procedures for ovarian cancer.卵巢癌的外科手术程序
Ann R Coll Surg Engl. 1986 Nov;68(6):315-8.
2
The role of chemotherapy including ifosfamide for ovarian carcinoma. Austrian Collab. Ovarian Cancer Study Group.
Cancer Chemother Pharmacol. 1990;26 Suppl:S30-2. doi: 10.1007/BF00685413.